The authors concluded that the transobturator approach is associated with a lower risk of complications than the retropubic approach to midurethral slings for stress incontinence, but there was insufficient evidence to compare the effects on other outcomes. The evidence appears to support this conclusion. However, limitations of the review make it difficult to determine the reliability of the results.
How were the studies combined?
The studies were grouped by study design (RCT or cohort) and outcome measure, and pooled using the random-effects model of DerSimonian and Laird where sufficient data on similar outcome measures were available and in a narrative synthesis otherwise. Pooled ORs with 95% confidence intervals (CIs) were calculated. Publication bias was assessed using a funnel plot and tested using the Begg and Egger test. Characteristics of additional trials that would be required to change the review findings were determined (details were reported).
How were differences between studies investigated?
Statistical heterogeneity was assessed using the Cochran Q statistic. Sensitivity analysis were conducted by excluding studies with short-term (less than 1 year) follow-up; changing event counts in each treatment arm; after omitting each study in turn; and using a different definition for subjective failure. There were insufficient data to undertake the planned subgroup analyses for women with mixed incontinence and women with intrinsic sphincter deficiency.
Results of the review
Eighteen studies (n=2,591) were included: 6 randomised controlled trials (RCTs; n=492) and 12 studies reporting 11 cohorts (n=2,099).
One RCT reported blinding of the patients and outcome assessors.
Objective outcomes.
One RCT assessed the results from a cough stress test; the results were not reported in the review. In cohort studies, objective failure (defined variously) was reported in 12.8% of women in the TO group and 13.7% of women in the RP group (based on 4 cohort studies, n=860).
Subjective outcomes.
There was no statistically significant difference in the risk of subjective failure between women in the TO and RP groups when using data from RCTs or cohort studies: OR 0.85 (95% CI: 0.38, 1.92; 5 RCTs) and OR 0.73 (95% CI: 0.38, 1.4; 8 cohort studies), respectively. Two RCTs reported improvement in quality of life scores post-operatively in both treatment groups. Three cohort studies assessed quality of life using validated measures. Two studies reported similar rates of post-operative improvement in both treatment groups and one reported 90% of all patients improved.
Peri-operative complications.
Complications were significantly less common among women in the TO group than among those in the RP group when using data from RCTs or cohort studies: 0.8% (2 out of 241) versus 12.2% (30 out of 246), OR 0.40 (95% CI: 0.19, 0.83; 6 RCTs) and 0.8% (7 out of 830) versus 5.5% (56 out of 1,024), OR 0.21 (95% CI: 0.10, 0.44; 10 cohort studies), respectively. For all studies combined, the most common complications were bladder perforation (3.5% in RP group versus 0.2% in TO group), haematoma (1.6% in RP group versus 0.08% in TO group) and infection (less than 1% in both groups).
De novo irritative voiding symptoms.
When using data from RCTs, there was no statistically significant difference in de novo irritative voiding symptoms between women in the TO and the RP groups (OR 0.54, 95% CI: 0.26, 1.1; 5 RCTs). When using data from cohort studies, de novo irritative voiding symptoms were significantly less common among women in the TO group than among those in the RP group (OR 0.44, 95% CI: 0.24, 0.80; 8 cohort studies).
Voiding dysfunction requiring reoperation.
One RCT and 6 cohort studies assessed this outcome. The authors stated that, overall, this outcome was rare and there were insufficient data for pooling.
The findings were robust to the sensitivity analyses, and there was no evidence of either statistical heterogeneity or publication bias in any of the analyses.
